Morgan Stanley Precipio, Inc. Transaction History

Morgan Stanley

  • $1.35 Trillion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.98 - $1.68 $93,474 - $160,241
-95,382 Closed
0 $0
Q1 2022

Oct 27, 2022
BUY
$1.19 - $1.71 $113,504 - $163,103
95,382 New
95,382 $129,000
Q1 2022

May 13, 2022
SELL
$1.19 - $1.71 $83,232 - $119,602
-69,943 Reduced 42.31%
95,382 $129,000
Q4 2021

Feb 14, 2022
SELL
$1.58 - $2.77 $649 - $1,138
-411 Reduced 0.25%
165,325 $261,000
Q3 2021

Nov 15, 2021
BUY
$2.78 - $3.63 $460,746 - $601,621
165,736 New
165,736 $467,000

Others Institutions Holding PRPO

# of Institutions
1
Shares Held
340
Call Options Held
0
Put Options Held
0
View Full List

About Precipio, Inc.

PRPO Quotes by TradingView
  • Ticker PRPO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 22,736,500
  • Market Cap $134M
  • Description
  • Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust geneti...
More about PRPO
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email